Best in Biotech 15 May 2018 Here Are 10 of the Hottest Biotech Hubs in Europe …Planegg. Right there is one of Europe’s largest biotechs: MorphoSys, a billion-euro biotech that develops antibody therapies. The city is also home to Medigene, which develops T cell receptor technology… May 15, 2018 - 10 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 1 Nov 2022 Human Immunology Biosciences launches with $120M …enhancements that come with our approach.” Clinical-stage assets HI-Bio’s clinical-stage assets include felzartamab, an anti-CD38 antibody, and HIB210, an anti-C5aR1 antibody. Felzartamab targets a protein expressed on the surface of… November 1, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Feb 2023 10 biotech companies making a difference in rare diseases …Founded: 2019 Alchemab Therapeutics is a biotechnology company working on harnessing the power of the immune system to create the next generation of antibody therapeutics for hard-to-treat diseases that do… February 28, 2023 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 6 Mar 2023 The biggest private biotech investments in February 2023 …will be used to finance an ongoing phase 1/2 trial of a bispecific antibody treatment for the rare bleeding condition Glanzmann thrombasthenia in addition to the launch of a phase… March 6, 2023 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 16 Nov 2020 Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal …deal’s terms, Affimed will receive €51M upfront to license to Roivant a preclinical-stage antibody drug for several undisclosed types of cancer. Roivant will handle the program once Affimed completes preclinical… November 16, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 1 Feb 2022 Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA …Series B round to fund the development of its lead candidate mRNA therapies — one for respiratory viral infections and the other for the genetic lung condition primary ciliary dyskinesia…. February 1, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 26 May 2023 Could new Lyme disease tests help to prevent chronic infection? …order to create a better Lyme disease test. Dr Abdo Alnabulsi, chief executive officer (CEO) of EpitogenX, stated: “We are working on a serology based antibody test for the detection… May 26, 2023 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 21 Feb 2018 FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s …type of monoclonal antibody known as a checkpoint inhibitor that targets the immune regulatory molecule PD-L1. The FDA approval for Imfinzi is the first authorization of a treatment for lung… February 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 12 Jun 2017 BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced… June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
Interview 8 Oct 2019 Biotech Hubs: A Tale of Two Cities …founded the online antibody provider Abcam in 1998. Under his leadership, the company grew to be worth over €2B today. Having met with success, Milner became an angel investor in… October 8, 2019 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 18 May 2017 Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug …comes in addition to Biogen’s Phase II antibody Natalizumab that blocks the recruitment of inflammatory cells. Similar to AptaTarget, French Acticor Biotech just raised €1.5M for its humanized antibody fragment… May 18, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Sponsored by ACROBiosystems 3 Nov 2022 Impacting vaccine development: COVID-19 and its implications for the future of vaccines …the vaccination route and frequency, thus impacting the design of the immunization program. The breakthrough COVID-19 vaccines underwent the same checks and balances, with antibody detection methods of ELISA and… November 3, 2022 - 8 minutesmins - By Sudha Sundaram Share WhatsApp Twitter Linkedin Email